Publications
- Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation2013 | Faculty of Medicine in Pilsen
- Pharmacoeconomic Impact of Different Regimens to Prevent Cytomegalovirus Infection in Renal Transplant Recipients2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Advances in cytomegalovirus preventive strategies in solid organ transplantation: defending pre-emptive therapy2012 | Faculty of Medicine in Pilsen
- Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients2011 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Intragraft cytomegalovirus infection: results of randomized trial of valacyclovir prophylaxis vs. preemptive valganciclovir therapy in renal transplant recipients2010 | Central Library of Charles University
- Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis2009 | Central Library of Charles University
- Perspective: Viral infections - still unresolved problem after kidney transplantation2009 | Central Library of Charles University
- Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation2008 | Central Library of Charles University
- The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection2006 | Faculty of Medicine in Pilsen, Central Library of Charles University
Loading network view...